Flexible Solutions International reported Q2 2026 sales of $7.61 million and a $1.91 million net loss attributed to scaling costs. The company anticipates returning to profitability in Q3 with project
Flexible Solutions International missed Q2 2026 estimates due to scale-up costs, but shares rose 5.56% on optimism for new food-grade contracts and a strategic pivot to food-grade products via NanoChe
Flexible Solutions International reported a 14% sales decrease and net loss for Q2 2026, citing scaling costs for food grade contracts and training. The company anticipates revenue growth from Panama,
Flexible Solutions International reported a Q2 2026 net loss of $1.9 million amid scaling costs. The company anticipates revenue growth in Q3 across its Panama, ENP, and NanoChem divisions.
Flexible Solutions International reported a Q2 net loss of $1.91 million due to scaling costs and training expenses. The company projects its Panama, ENP, and NanoChem divisions will generate over $12
Flexible Solutions International reported a Q2 2026 net loss of $1.9 million due to margin compression and higher operating costs. The company maintained positive operating cash flow and secured a reg
Flexible Solutions International Inc reported Q2 2026 revenue of $7.61 million, down from $11.37 million, with a diluted EPS of ($0.15). The decline was attributed to startup delays at the Panama faci
Flexible Solutions International Inc. reported $38.52 million in annual revenue, with its Biodegradable Polymers segment accounting for $35.63 million. The majority of sales were generated from the Un
Flexible Solutions International reported a 35% year-over-year revenue decline to $7.4 million in Q2 2026, attributed to lost R&D contracts and delayed shipments, described by the CEO as an historical
Flexible Solutions International Inc reported a 35% YoY revenue decline to $7.4 million for Q2 2026 due to lost R&D contracts and operational delays. The company plans to expand into food and nutritio
Flexible Solutions International Inc reported a 35% Q2 revenue decline to $7.4 million, driven by the absence of non-recurring R&D services revenue and shipment delays. Full financial results are sche
Flexible Solutions International reported a 35% decrease in Q2 2026 revenue to $7.4 million, attributed to prior-year R&D anomalies and shipment delays, though management expressed optimism for recove
Flexible Solutions International Inc reported regional revenue data as of April 6, generating $10.34 million from the United States and $215.23 thousand from Canada.
Flexible Solutions International missed Q1 2026 forecasts, triggering a stock dip despite improved cash flow. The firm is pivoting toward food-grade products amid challenges from raw material volatili
Flexible Solutions International reported a net loss of $0.02 per share in Q1 2026, missing analyst expectations and dropping its stock price. Management cites optimism for future profits driven by ex
Flexible Solutions International reported Q1 2026 sales of $8.30 million, up 11%, with narrowed losses and positive operating cash flow. CEO cited increased Panama plant output and a new food contract
Flexible Solutions International reported an 11% sales increase to $8.3 million in Q1 2026, driven by NanoChem and ENP divisions despite a small net loss. Profitability is expected to improve in H2 20
Flexible Solutions International reported an 11% Q1 sales increase to $8.3 million, driven by production ramp-up for a major contract and expansion via its NanoChem division and Panama factory.
Flexible Solutions International reported an 11% sales increase to $8.29 million for Q1 2026, posting positive non-GAAP operating cash flow despite a net loss. A conference call is scheduled for May 1
Flexible Solutions International Inc reported an 11% increase in Q1 2026 revenue to $8.3 million, though it posted a net loss of $241,420 due to expansion costs and a new Panama factory.
Flexible Solutions International reported an 11% year-over-year revenue increase to $8.3 million for Q1 2026, driven by a new food-grade contract. The company anticipates stronger performance in the r
ChemBrief